Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Immatics N.V. Warrants (IMTXW)

https://www.immatics.com

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/02/2020

Market Cap

1,206,755,832

Shares Outstanding

84,660,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ATNFW --.--%

ARTLW --.--%

BCDAW --.--%

IMACW --.--%

ENTXW --.--%

Beta

0.7470

Last Div

0.0000

Range

2.55-2.55

Chg

0.0600

Avg Vol

N/A

Mkt Cap

1206755832

Exch

NASDAQ

Country

US

Phone

49 7071 5397 0

DCF Diff

18.6399

DCF

-7.1699

Div Yield

0.0000

P/S

15.1950

EV Multiple

-10.9602

P/FV

2.8490

Div Yield %

0.0000

P/E

-15.1161

PEG

-0.5405

Payout

0.0000

Current Ratio

3.7388

Quick Ratio

3.7388

Cash Ratio

1.0575

DSO

14.5135

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-1.4216

Pretax Margin

-1.0128

Net Margin

-1.0342

Eff Tax Rate

-0.0241

ROA

-0.1166

ROE

-0.2318

ROCE

-0.2105

NI/EBT

1.0211

EBT/EBIT

0.7124

EBIT/Rev

-1.4216

Debt Ratio

0.0347

D/E

0.0561

LT Debt/Cap

0.0000

Total Debt/Cap

0.0532

Int Coverage

-108.8146

CF/Debt

-0.8587

Equity Multi

1.6164

Rec Turnover

25.1490

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

1.0892

Asset Turnover

0.1128

OCF/Share

-0.1765

FCF/Share

-0.4336

Cash/Share

5.0125

OCF/Sales

-0.2645

FCF/OCF

2.4567

CF Coverage

-0.8587

ST Coverage

-0.8587

CapEx Coverage

-0.6865

Div&CapEx Cov

-0.6865

P/BV

2.8490

P/B

2.8490

P/S

15.1950

P/E

-15.1161

P/FCF

-23.3839

P/OCF

-59.0995

P/CF

-59.0995

PEG

-0.5405

P/S

15.1950

EV Multiple

-10.9602

P/FV

2.8490

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 08, 22:00 Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME GlobeNewswire Inc. Oct 11, 00:50 Immatics Announces Pricing of $150 Million Public Offering

Revenue Product Segmentation